ISPOR 3rd Latin America Conference - Released Presentations
 

RELEASED PRESENTATIONS

PLENARY SESSIONS
(Presentations to be added pending speaker approval)
FIRST PLENARY SESSION:
UNIVERSAL COVERAGE IN THE FACE OF RISING COSTS OF NEW HEALTH CARE TECHNOLOGIES: IS IT ACHIEVABLE?
RETOS PARA LA COBERTURA UNIVERSAL FRENTE A LOS ALTOS COSTOS DE NUEVAS TECNOLOGIAS EN SALUD

Moderator: María-Luisa Escobar, PhD, Lead Health Economist, Manager, Health Practice, World Bank Institute, Washington DC, USA
Moderadora: María-Luisa Escobar, PhD, Economista de Salud Principal, Gerente, Práctica de Sistemas de Salud, Banco Mundial, Washington DC, USA

UNIVERSALITY OF HEALTH SERVICES (THE MEXICAN CASE)
Mercedes Juan-López, MD, Executive President, FUNSALUD, Mexico City, Mexico
UNIVERSALIDAD DE SERVICIOS DE SALUD (EL CASO MEXICANO)
Dra. Mercedes Juan-López, Presidenta Ejecutiva, FUNSALUD, México D,F., México 

UNIVERSAL COVEREAGE IN HEALTH CARE (THE CHILEAN CASE)
Luis Romero Strooy, MBA, Superintendent of Health, Superintendence of Health, Government of Chile, Santiago, Chile
COBERTURA UNIVERSAL EN SALUD (EL CASO CHILENO)
Sr. Luis Romero Strooy, MBA, Superintendente de Salud, Superintendencia de Salud, Gobierno de Chile, Santiago, Chile 

THE HEALTH CARE SYSTEM IN ARGENTINA AND THE REGULATION OF NEW HEALTH CARE TECHNOLOGIES
Guillermo Williams, MD, Director, National Board of Health Regulation and Quality Health Care, Ministry of Health, Buenos Aires, Argentina
SISTEMA SANITARIO EN ARGENTINA Y REGULACION DENUEVAS TECNOLOGIAS EN SALUD
Dr. Guillermo I. Williams, Director Nacional de Regulación Sanitaria y Calidad en Servicios de Salud, Ministerio de Salud de la Nación, Buenos Aires, Argentina

 

SECOND PLENARY SESSION:
WHAT IS THE VALUE OF HEALTH OUTCOMES RESEARCH TO DECISION-MAKERS: A CANDID DISCUSSION WITH PUBLIC DECISION-MAKERS
¿CUAL ES EL VALOR DE LA INVESTIGACION DE RESULTADOS PARA LOS TOMADORES DE DECISIONES?: UNA DISCUSION FRANCA ENTRE TOMADORES DE DECISIONES EN INSTITUCIONES PÚBLICAS

Moderator: J. Jaime Caro MDCM, FRCPC, FACP, Adjunct Professor of Medicine, Adjunct Professor of Epidemiology and Biostatistics, McGill University, Montreal PQ & Senior Vice-President of Health Economics, United BioSource Corporation, Lexington, MA, USA
Moderador: Dr. J. Jaime Caro, Profesor Adjunto de Medicina, Profesor Adjunto de Epidemiología y Bioestadística, McGill University, Montreal PQ y Vice-presidente senior de Economia de la Salud, United BioSource Corporation, Lexington, MA, USA

ARE HEALTH ECONOMIC EVALUATIONS USED IN MEXICO FOR HEALTH CARE DECISION MAKING?
Juan Garduño Espinosa, MD, Deputy Director, Research Management, Research Department, "Federico Gómez" Children’s Hospital of Mexico, México City, Mexico
¿SE UTILIZAN LAS EVALUACIONES ECONOMICAS EN MÉXICO PARA LA TOMA DE DECISIONES EN EL AREA DE LA SALUD?
Dr. Juan Garduño Espinosa, Subdirector de Gestión de Investigación, Dirección de Investigación, Hospital Infantil de México "Federico Gómez", México D.F., México

USE OF HEALTH OUTCOMES RESEARCH IN DECISION-MAKING IN ARGENTINA
Tomás A. Pippo Briant, MA, MPH, Director of Health Economics, Ministry of Health, Buenos Aires, Argentina
EL USO DE LA INVESTIGACION DE RESULTADOS EN EL AREA DE LA SALUD EN ARGENTINA
Lic. Tomás A. Pippo Briant, Director de Economía de la Salud del Ministerio de Salud, Buenos Aires, Argentina

THE HEALTH CARE DECISION-MAKING PROCESS IN URUGUAY
Alarico Rodriguez MD, Medical Benefits Manager, Uruguayan National Agency for Highly Specialized Medical Procedures, Montevideo, Uruguay 
EL PROCESO DE TOMA DE DECISIONES SANITARIAS EN URUGUAY
Dr. Alarico Rodriguez, Gerente de Beneficios Médicos, Fondo Nacional de Recursos, Montevideo, Uruguay

 

PODIUM AND POSTER PRESENTATIONS
 

For contributed research podium and poster abstracts and released slide or poster presentations for the ISPOR 3rd Latin America Conference, see: ISPOR Outcomes Research Digest an electronic database of over 17,000 research papers presented at ISPOR Annual International Meetings, ISPOR Annual European Congresses, and biennial ISPOR Asia-Pacific & Latin America Conferences from 1998 to date.

  • ISPOR Outcomes Research Digest:  http://www.ispor.org/research_study_digest/research_index.asp
  • Under Meeting select 3rd Latin America Conference - Mexico City, Mexico - 2011
  • Select Search for all research podium and poster abstracts and available slide or poster presentations from the meeting. Alternatively search by disease/disorder, topic or subtopic.

ISSUE PANEL PRESENTATIONS

(Presentations to be added pending speaker approval)

 

IP1: HTA LEVEL OF INFLUENCE: TO WHAT EXTENT DO HTAS INFLUENCE MARKET ACCESS DECISIONS ACROSS GEOGRAPHIES?

 


IP2: RISK-SHARING SCHEMES IN EMERGING COUNTRIES: WHAT ARE THE STEPS FOR SUCCESS?

Risk‐Sharing Schemes in Emerging Countries: What Are the Steps for Success?
Lou Garrison, PhD, Professor, Pharmaceutical Outcomes Research and Policy Program, University of Washington School of Pharmacy, Seattle, WA, USA

Risk‐Sharing Agreements: Global Trends and Barriers
Sean D. Sullivan, PhD, RPh, MS, Professor & Director, Pharmaceutical Outcomes Research and Policy Program, University of Washington School of Pharmacy, Seattle, WA, USA

Health Economic and Outcomes Researches in Emerging Market: Asia as an example on how industry adapts to the ever
changing environment

Jianwei Xuan, PhD, Senior Director and Team Leader, Pfizer, New York, NY, USA  


IP3:  EL PAPEL DE LAS AGENCIAS DE EVALUACIÓN DE TECNOLOGÍAS EN AMÉRICA LATINA

El Papel del las agencias de evaluacion de tecnologias en America Latina
Iris Contreras, MD, MSc, Clinical Researcher, Mexican Institute of Social Security, Mexico D.F., Mexico

El Papel del las agencias de evaluacion de tecnologias en Salud (ETES) America Latina - MÉXICO
Esteban Hernandez-San Roman, MD, Director, Evaluation of Health Technologies, The National Center for Health Technology Excellence, México D.F., México

Evaluación de Tecnologías Sanitarias: Situación de Chile y su rol en la región
Luis Vera, MD, MSc, Professional Adviser, Health Technology Assessment, Department of Quality and Safety Patient, Ministry of Health, Santiago, Chile

Las actividades del IECS se concentran en tres areas complementarias: Investigación, Docencia y Asistencia Técnica
Sebastián García Martí, MD, MSc, Health Technology Assessment & Economic Evaluation, IECS, Buenos Aires, Argentina


IP4: EL COSTO DE LOS TRASTORNOS DEL ESTADO DE ÁNIMO: ¿QUÉ ASPECTO GENERA EL MAYOR GASTO PARA LOS SISTEMAS DE SALUD? ¿QUÉ GENERA LA ALTA DISCAPACIDAD ASOCIADA? UNA PERSPECTIVA SOCIAL, ECONÓMICA Y GLOBAL

ESTUDIO DESCRIPTIVO DE LOS COSTOS DIRECTOS Y Ó ESTIMACIÓN DE GASTO CATASTRÓFICO DE LA DEPRESIÓN EN PACIENTES DEL INSTITUTO NACIONAL DE PSIQUIATRÍA “RAMÓN DE LA FUENTE”
Jeremy Cruz, MD, Universidad Nacional Autónoma de México/INP, México D.F., México

DISCAPACIDAD Y COSTOS INDIRECTOS ASOCIADOS AL TRATAMIENTO DE LA DEPRESIÓN EN PACIENTES DEL SERVICIO DE CONSULTA EXTERNA EN EL INSTITUTO NACIONAL DE PSIQUIATRÍA “RAMÓN DE LA FUENTE”
Mauricio Palma, MSc, MD, Estudiente de psiquiatriat, Secretaria de Salud, Instituto Nacional de Psiquiatría, México D.F., México

La carga social del Trastorno bipolar: percepciones del paciente
Ingrid Vargas, MD, MSc, Investigadora, Académica, Departamento de Psiquiatría y Salud Mental, Universidad Nacional Autónoma de México, México D.F., México


 
 WORKSHOP PRESENTATIONS

(Presentations to be added pending speaker approval)

 
W1: METHODS FOR THE CRITICAL REVIEW OF COST-EFFECTIVENESS MODELS SUBMITTED TO REIMBURSEMENT AUTHORITIES: LEARNING FROM INTERNATIONAL EXPERIENCE

METHODS FOR THE CRITICAL REVIEW OF COST EFFECTIVENESS MODELS SUBMITTED TO REIMBURSEMENT AUTHORITIES
Mark J. Sculpher, PhD, Professor of Health Economics, Centre for Health Economics, University of York and Senior Advisor, Oxford Outcomes Ltd., Heslington, York, UK

METHODS FOR THE CRITICAL REVIEW OF COST EFFECTIVENESS MODELS SUBMITTED TO REIMBURSEMENT AUTHORITIES: LEARNING FROM INTERNATIONAL EXPERIENCE
Federico Augustovski, MD, MSc, Director, Health Economic Evaluation and Technology Assessment Department, Hospital Italiano de Buenos Aires, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina

New Health Technologies and Brazilian Health Care System
Clarice Petramale, PhD, Health Technology Incorporation Commission - CITEC, Department of Science, Technology and Strategic Supplies, Ministry of Health, Brasilia, Brazil

W4: GUIDELINES FOR APPROPRIATE SELECTION OF MODELING APPROACH IN PHARMACOECONOMIC EVALUATION IN LATIN AMERICA

GUIDELINES FOR APPROPRIATE SELECTION OF MODELING APPROACH IN PHARMACOECONOMIC EVALUATION IN LATIN AMERICA
Joaquin Federico Mould Quevedo, PhD, MBA, MSc, Health Economics & Outcomes Research Director, Pfizer, Inc., New York, NY, USA

W5: EQ-5D: A KEY PART OF THE LATIN AMERICAN DECISION-MAKERS' TOOLKIT

TARIFA NORMATIVA CHILENA. ASPECTOS METODOLÓGICOS DE LA APLICACIÓN DEL EQ-5D
Victor Zarate, MD, MSc, PhD Student, Centre for Health Economics, University of York, York, UK

MediciÓn online de la salud auto-percibida en Chile: AnÁlisis de la aplicaciÓn de la encuesta EQ-5D en el web de la Superintendencia de Salud
Catalina Gutierrez, MSc, Researcher, Departamento de Salud Pública, Universidad de Los Andes, Santiago, Chile

W6: EVALUACIÓN DE TECNOLOGÍAS SANITARIAS EN CHILE: PASADO, PRESENTE Y FUTURO

EvaluaciÓn de Tecnologías Sanitarias en Chile: Pasado, Presente y Futuro
Manuel Antonio Espinoza, MD, MSc, Académico, Departamento de Salud Pública, Pontificia Universidad Católica de Chile, Santiago, Chile

El desarrollo de la EvaluaciÓn EconÓmica en Chile
Marianela Castillo, MSc, Economista de la Salud, Ministerio de Salud de Chile, Santiago, Chile

EvaluaciÓn de TecnologÍas Sanitarias: ¿QuÉ hemos hecho en Chile?
Luis Vera, MD, MSc, Departamento de Calidad y Seguridad del Paciente, Ministerio de Salud de Chile, Santiago, Chile

W7: THE ROLE OF HEALTH ECONOMIC AND OUTCOMES RESEARCH (HEOR) EVIDENCE IN FORMULARY AND REIMBURSEMENT DECISIONS IN LATIN AMERICA VERSUS THE UNITED STATES

THE ROLE OF HEALTH ECONOMIC AND OUTCOMES RESEARCH (HEOR) EVIDENCE IN FORMULARY AND REIMBURSEMENT DECISIONS IN LATIN AMERICA VS. THE UNITED STATES
Anke-Peggy Holtorf, PhD, MBA, Adjunct Faculty, Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, UT, USA

THE ROLE OF HEALTH ECONOMIC AND OUTCOMES RESEARCH (HEOR) EVIDENCE IN FORMULARY AND REIMBURSEMENT DECISIONS IN LATIN AMERICA VERSUS THE UNITED STATES
Gary Oderda, PharmD, MPH
, Professor and Director, Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USA

W8: METHODS FOR INDIRECT AND MIXED TREATMENT COMPARISONS: TOOLS FOR ASSESSING HEALTH TECHNOLOGIES IN THE ABSENCE OF DIRECT EVIDENCE

MÉtodos de Comparaciones Mixtas e Indirectas: Herramientas para Evaluar TecnologÍas de Salud en ausencia de Evidencia Directa
Rafael Alfonso-Cristancho, MD, MSc, Research Associate, School of Pharmacy, Pharmaceutical Outcomes Research & Policy Program, University of Washington, Seattle, WA, USA

MÉtodos de Comparaciones Mixtas e Indirectas: Herramientas para Evaluar TecnologÍas de Salud en ausencia de Evidencia Directa
Ximena Burbano-Levy, MD, Project Director, School of Integrated Sciences and Humanity, Miami, FL, USA

W10: A LACK OF LOCAL EFFECTIVENESS, COST AND EPIDEMIOLOGIC DATA: WHAT ARE THE OPTIONS FOR CONDUCTING PE STUDIES IN LATIN AMERICA?

¿Es indispensable tener informaciÓn Local para desarrollar evaluaciones econÓmicas?
Rafael Alfonso-Cristancho, MD, MSc, Research Associate, School of Pharmacy, Pharmaceutical Outcomes Research & Policy Program, University of Washington, Seattle, WA, USA

La SituaciÓn en MÉxico
Rosa Maria Galindo-Suarez, MSc, Outcomes Research Manager, Pfizer, México D.F., México

W12: THE FUTURE OF PHARMACEUTICAL COST CONTROLS IN LATIN AMERICA: HTA OR REFERENCE PRICING?

THE FUTURE OF PHARMACEUTICAL COST CONTROLS IN LATIN AMERICA: HTA OR REFERENCE PRICING?
Monica Martin de Bustamante, AB, Fellow, Global Market Access, Insight Strategy Advisors, New York, NY, USA

THE FUTURE OF PHARMACEUTICAL COST CONTROLS IN LATIN AMERICA: HTA OR REFERENCE PRICING?
A. Chowdhury, MSc, Vice President, Global Market Access, Insight Strategy Advisors, New York, NY, USA

 
EDUCATIONAL SYMPOSIA

(Presentations to be added pending symposia host approval)

 

HOW CAN WE AVOID A STROKE CRISIS IN LATIN AMERICA? A REPORT FROM AN INDEPENDENT WORKING GROUP
(Sponsored by Bayer HealthCare)
Carlos Cantú, MD, Professor of Stroke Program, National University of Mexico, Stroke Clinic, Department of Neurology, National Institute of Medical Sciences and Nutrition, Salvador Zubiran, Mexico and Founding Member of the Mexican Stroke Association, Mexico City, Mexico 

The Burden of Stroke and Atrial Fibrillation
Jorge Gonzalez-Zuelgaray, MD, Chief of Service of Arrhythmias and Electrophysiology (Sanatorio de la Trinidad San Isidro, Buenos Aires, Argentina), Director of Arrhythmia Center, University of Buenos Aires; President of Arrhythmia Alliance and Atrial Fibrillation Association in Argentina, Director, Career of Specialists in Electrophysiology, University of Buenos Aires, Buenos Aires, Argentina

The Patient Perspective
Trudie Lobban, MBE, Founder & Trustee, Arrhythmia Alliance, Founder and Chief Executive Officer, Atrial Fibrillation Association, Buenos Aires, Argentina

STRIKING THE RIGHT LEVEL: "MICRO AND MACRO" HTA IN EMERGING MARKETS / HEALTH SYSTEMS
(Sponsored by PhRMA )

HEALTH ECONOMIC ANALYSIS IN LATIN AMERICA: CAN LESSONS LEARNED FROM OTHER PARTS OF THE WORLD BE APPLIED?
(Sponsored by IMS Consulting Group)

STATUS UPDATE OF THE REIMBURSEMENT REVIEW ENVIRONMENT ACROSS LATIN AMERICA
(Sponsored by Millcreek Outcomes Group)

Mexico
Iris Contreras Hernandez, MD, MS, Head of Internal Medicine, General Hospital Zone No. 1-A “Los Venados”, IMSS, Mexico City, Mexico

Argentina
Federico Augustovski, MD, MSc, Director, Health Economic Evaluation and Technology Assessment, IECS (Institute for Clinical Effectiveness and Health Policy) & Staff Physician, Family and Community Medicine Division, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

Colombia
Jorge Augusto Diaz Rojas, MSc (Pharmacology), MSc (Economics), PhD (c), Associate Professor, Hospital and Clinical Pharmacy Unit, College of Pharmacy, Universidad Nacional de Colombia, Bogotá, Colombia

Brazil
Marcos B. Ferraz, MD, PhD, Associate Professor & Director, São Paulo Center for Health Economics, Department of Medicine, Federal University of São Paulo and Medical Director, Brazilian Medical Association, São Paulo, Brazil


3rd Latin America Conference Main Page